An Update on the Medical Management of Prostate Cancer â MM1601
Over the past decade many advances have been made in the medical management of prostate cancer. Various treatment options are now available to patients, nearly all of which have distinct mechanisms of action that can improve survival in those with progressive metastatic prostate cancer.
Modern Medicine â January 2016
An Update on Testosterone Replacement Therapies â MM1505
Effective treatments for testosterone deficiency are available for men at all ages. The choice of testosterone preparation depends on several factors, including length and severity of testosterone deficiency, pharmacokinetic profiles of the available preparations and the patientâs age, comorbidities and personal preference.
Modern Medicine â May 2015
Current Concepts of Low Testosterone Levels in Ageing Men â MM1504
Low testosterone levels are associated with increased risk of cardiovascular disease and increased mortality in ageing men. Men with pathologically based hypogonadism should be considered for testosterone supplementation. For older men suspected of being androgen deficient in the absence of pituitary or testicular disease, controversy exists because symptoms can be nonspecific, the definition of low testosterone levels is under debate and the risks of extended treatment are uncertain.
Modern Medicine â April 2015
Erectile Dysfunction: A Guide for GPs – MM1308
Erectile dysfunction is a serious matter. Not only can this cause great distress for a man and his partner, but it is an important marker of underlying comorbidities, including future cardiovascular disease.
Modern Medicine â August 2013
Hypogonadism in Men: How to Evaluate and When to Treat â MM1306
Low testosterone levels may be due to underlying disease or lifestyle factors that need to be addressed before testosterone supplementation is considered.
Modern Medicine â June 2013
